Cargando…
AEG-1 targeting for inhibiting inflammation: potential anti-HCC strategy
Autores principales: | Reghupaty, Saranya Chidambaranathan, Mendoza, Rachel, Sarkar, Devanand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363015/ https://www.ncbi.nlm.nih.gov/pubmed/30774759 http://dx.doi.org/10.18632/oncotarget.26602 |
Ejemplares similares
-
The multifaceted oncogene SND1 in cancer: focus on hepatocellular carcinoma
por: Chidambaranathan-Reghupaty, Saranya, et al.
Publicado: (2018) -
Current Status of Gene Therapy in Hepatocellular Carcinoma
por: Reghupaty, Saranya Chidambaranathan, et al.
Publicado: (2019) -
Dysregulation of Type I Interferon (IFN-I) Signaling: A Potential Contributor to Racial Disparity in Hepatocellular Carcinoma (HCC)
por: Reghupaty, Saranya Chidambaranathan, et al.
Publicado: (2023) -
Multifunctional Role of Astrocyte Elevated Gene-1 (AEG-1) in Cancer: Focus on Drug Resistance
por: Manna, Debashri, et al.
Publicado: (2021) -
The Scope of Astrocyte Elevated Gene-1/Metadherin (AEG-1/MTDH) in Cancer Clinicopathology: A Review
por: Khan, Maheen, et al.
Publicado: (2021)